
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 891708
[patent_doc_number] => 07344884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'Peptides promoting cell adherence, growth and secretion'
[patent_app_type] => utility
[patent_app_number] => 11/351132
[patent_app_country] => US
[patent_app_date] => 2006-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11195
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/344/07344884.pdf
[firstpage_image] =>[orig_patent_app_number] => 11351132
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/351132 | Peptides promoting cell adherence, growth and secretion | Feb 8, 2006 | Issued |
Array
(
[id] => 5859776
[patent_doc_number] => 20060229252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Antimicrobial hexapeptides'
[patent_app_type] => utility
[patent_app_number] => 11/350192
[patent_app_country] => US
[patent_app_date] => 2006-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17465
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229252.pdf
[firstpage_image] =>[orig_patent_app_number] => 11350192
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/350192 | Antimicrobial hexapeptides | Feb 7, 2006 | Issued |
Array
(
[id] => 5632569
[patent_doc_number] => 20060149039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Pseudo-native chemical ligation'
[patent_app_type] => utility
[patent_app_number] => 11/340730
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26808
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20060149039.pdf
[firstpage_image] =>[orig_patent_app_number] => 11340730
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/340730 | Pseudo-native chemical ligation | Jan 26, 2006 | Abandoned |
Array
(
[id] => 5913563
[patent_doc_number] => 20060128625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Povidone-containing carriers for polypeptide growth factors'
[patent_app_type] => utility
[patent_app_number] => 11/338914
[patent_app_country] => US
[patent_app_date] => 2006-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7082
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128625.pdf
[firstpage_image] =>[orig_patent_app_number] => 11338914
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/338914 | Povidone-containing carriers for polypeptide growth factors | Jan 24, 2006 | Issued |
Array
(
[id] => 5041129
[patent_doc_number] => 20070093411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Zinc-free and low-zinc insulin preparations having improved stability'
[patent_app_type] => utility
[patent_app_number] => 11/337855
[patent_app_country] => US
[patent_app_date] => 2006-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3437
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20070093411.pdf
[firstpage_image] =>[orig_patent_app_number] => 11337855
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/337855 | Zinc-free and low-zinc insulin preparations having improved stability | Jan 22, 2006 | Abandoned |
Array
(
[id] => 4873646
[patent_doc_number] => 20080200380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Compositions For Buccal Delivery Of Parathyroid Hormone'
[patent_app_type] => utility
[patent_app_number] => 11/813700
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13328
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200380.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813700
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813700 | Compositions for buccal delivery of parathyroid hormone | Jan 11, 2006 | Issued |
Array
(
[id] => 817141
[patent_doc_number] => 07410949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-12
[patent_title] => 'Neuropeptide-2 receptor (Y-2R) agonists and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/328743
[patent_app_country] => US
[patent_app_date] => 2006-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17013
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/410/07410949.pdf
[firstpage_image] =>[orig_patent_app_number] => 11328743
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/328743 | Neuropeptide-2 receptor (Y-2R) agonists and uses thereof | Jan 9, 2006 | Issued |
Array
(
[id] => 4772763
[patent_doc_number] => 20080058422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Antineoplastic Preparation and the Use of Antineoplastic Preparation'
[patent_app_type] => utility
[patent_app_number] => 11/813526
[patent_app_country] => US
[patent_app_date] => 2006-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 1934
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058422.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813526
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813526 | Antineoplastic preparation and the use of antineoplastic preparation | Jan 9, 2006 | Issued |
Array
(
[id] => 5515392
[patent_doc_number] => 20090215699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Pharmaceutically Active Antiviral Peptides'
[patent_app_type] => utility
[patent_app_number] => 11/722865
[patent_app_country] => US
[patent_app_date] => 2006-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18990
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215699.pdf
[firstpage_image] =>[orig_patent_app_number] => 11722865
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/722865 | Pharmaceutically Active Antiviral Peptides | Jan 4, 2006 | Abandoned |
Array
(
[id] => 795651
[patent_doc_number] => 07429567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-30
[patent_title] => 'Sustained delivery of PDGF using self-assembling peptide nanofibers'
[patent_app_type] => utility
[patent_app_number] => 11/320468
[patent_app_country] => US
[patent_app_date] => 2005-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8479
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/429/07429567.pdf
[firstpage_image] =>[orig_patent_app_number] => 11320468
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/320468 | Sustained delivery of PDGF using self-assembling peptide nanofibers | Dec 28, 2005 | Issued |
Array
(
[id] => 322624
[patent_doc_number] => 07517857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-14
[patent_title] => 'Immune-modulating peptide'
[patent_app_type] => utility
[patent_app_number] => 11/317924
[patent_app_country] => US
[patent_app_date] => 2005-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 26
[patent_no_of_words] => 12235
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/517/07517857.pdf
[firstpage_image] =>[orig_patent_app_number] => 11317924
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/317924 | Immune-modulating peptide | Dec 22, 2005 | Issued |
Array
(
[id] => 5453185
[patent_doc_number] => 20090069222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Compounds Useful as Modulators of the Proteasome Activity'
[patent_app_type] => utility
[patent_app_number] => 11/918060
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 37910
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069222.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918060
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918060 | Compounds useful as modulators of the proteasome activity | Dec 21, 2005 | Issued |
| 11/316316 | Immunologic regulation by theta defensins | Dec 20, 2005 | Abandoned |
Array
(
[id] => 4432781
[patent_doc_number] => 07897565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-01
[patent_title] => 'Compositions for HCV treatment'
[patent_app_type] => utility
[patent_app_number] => 11/720105
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7351
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/897/07897565.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720105
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720105 | Compositions for HCV treatment | Dec 19, 2005 | Issued |
Array
(
[id] => 5514158
[patent_doc_number] => 20090214464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'COMPOUNDS FOR FLAVIVIRIDAE TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 11/719684
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10124
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214464.pdf
[firstpage_image] =>[orig_patent_app_number] => 11719684
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/719684 | COMPOUNDS FOR FLAVIVIRIDAE TREATMENT | Dec 19, 2005 | Abandoned |
Array
(
[id] => 5754594
[patent_doc_number] => 20060223743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Metabolites of cyclosporin analogs'
[patent_app_type] => utility
[patent_app_number] => 11/313239
[patent_app_country] => US
[patent_app_date] => 2005-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 26734
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223743.pdf
[firstpage_image] =>[orig_patent_app_number] => 11313239
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/313239 | Metabolites of cyclosporin analogs | Dec 18, 2005 | Abandoned |
Array
(
[id] => 4813856
[patent_doc_number] => 20080194487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Treatment of Skin Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/795044
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 941
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194487.pdf
[firstpage_image] =>[orig_patent_app_number] => 11795044
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/795044 | Treatment of Skin Diseases | Dec 14, 2005 | Abandoned |
Array
(
[id] => 252685
[patent_doc_number] => 07579319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-25
[patent_title] => 'Methods for improving the structure and function of arterioles'
[patent_app_type] => utility
[patent_app_number] => 11/296582
[patent_app_country] => US
[patent_app_date] => 2005-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 29
[patent_no_of_words] => 30091
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579319.pdf
[firstpage_image] =>[orig_patent_app_number] => 11296582
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/296582 | Methods for improving the structure and function of arterioles | Dec 5, 2005 | Issued |
Array
(
[id] => 6477383
[patent_doc_number] => 20100041584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'GEM DIFLUORINATED C-GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE FOR THE PRESERVATION OF BIOLOGICAL MATERIALS AND/OR IN CRYOSUGERY'
[patent_app_type] => utility
[patent_app_number] => 11/720670
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 15650
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20100041584.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720670
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720670 | Gem difluorinated C-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosugery | Dec 1, 2005 | Issued |
Array
(
[id] => 6258438
[patent_doc_number] => 20100029911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Method For Solid-Phase Peptide Synthesis And Purification'
[patent_app_type] => utility
[patent_app_number] => 11/791342
[patent_app_country] => US
[patent_app_date] => 2005-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10722
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029911.pdf
[firstpage_image] =>[orig_patent_app_number] => 11791342
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/791342 | Method For Solid-Phase Peptide Synthesis And Purification | Nov 23, 2005 | Abandoned |